S0025: Phase II Trial Of Irinotecan (CAMPTOSAR) For Patients With Platinum And Taxane Refractory Ovarian, Peritoneal Or Fallopian Tube Cancer
Phase of Trial: Phase II
Latest Information Update: 07 Nov 2013
At a glance
- Drugs Irinotecan (Primary)
- Indications Fallopian tube cancer; Ovarian cancer; Peritoneal cancer
- Focus Therapeutic Use
- 16 Nov 2012 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
- 06 Mar 2008 Status changed from in progress to completed, as reported by ClinicalTrials.gov.
- 18 Sep 2005 New trial record.